摘要:胰高血糖素样肽-1(GLP-1)类似物艾塞那肽(exenatide)是近年来在2型糖尿病治疗领域中研发出的以双激素缺陷为靶向的新型降糖药物之一。其具有降低血糖而不引起低血糖且有降低体重的作用,另有报道其具有心血管保护作用和抑制乳腺癌细胞增长作用。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
High Technology Letters Particuology Tsinghua Science and Technology Journal of Integrative Plant Biology Journal of Integrative Agriculture Chinese Journal of Oceanology and Limnology Current Zoology Acta Oceanologica Sinica Journal of Energy Chemistry Acta Geologica Sinica Cellular Molecular Immunology Acta Metallurgica Sinica